Liver Invest Information

Companies
GENFIT Announces NIS2+® as Instrumental Tool in New Clinical Practice Guidelines for MAFLD Jun 17, 2024
Pharmaceuticals
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment Jun 12, 2024
Pharmaceuticals
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis Jun 11, 2024
Earnings
GENFIT Announces Q3 2023 Financial Results with Cash Reserves and Revenue Insights Nov 10, 2023
GENFIT Announces Third Quarter 2023 Financial Outcomes and Update on R&D Progress Nov 10, 2023